Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Babcock & Wilcox Co (BWC): Blue Harbour Group Boosts Activist Stake To 9.9%

Page 1 of 2

Blue Harbour Group, the hedge fund led by Clifton S. Robbins, has increased its activist stake in Babcock & Wilcox Co (NYSE:BWC). Blue Harbour, in a newly-amended filing made with the U.S. Securities and Exchange Commission, disclosed that it holds 10.54 million shares of Babcock & Wilcox Co (NYSE:BWC), up from 9.14 million shares the fund held earlier. The new stake is equal to 9.9% of the company’s common stock shares outstanding. In its latest 13F filing, Blue Harbour reported ownership of 7.33 million shares of Babcock & Wilcox Co (NYSE:BWC).

Clifton Robbins - Blue Harbour

Blue Harbour was founded in 2004 by Clifton Robbins, who is a former partner at private equity giant KKR. Blue Harbour Group mainly invests in Technology, Basic Material, Industrial Goods, and Services stocks. The value of the fund’s equity portfolio totaled $2.5 billion as of the end of September 2014. In its latest 13F, the fund revealed holding largest stakes, in terms of value, in Akamai Technologies Inc. (NASDAQ:AKAM), Rackspace Hosting Inc. (NYSE:RAX), and Rowan Companies PLC (NYSE:RDC). The fund disclosed ownership of 4.98 million shares of Akamai Technologies Inc. (NASDAQ:AKAM) as of the end of September 2014. Blue Harbour Group was bullish on Rackspace Hosting Inc. (NYSE:RAX) during the third quarter of 2014, as the fund boosted its stake in the company by over 150% to around 9.10 million shares. In addition, Blue Harbour loves Rowan Companies PLC (NYSE:RDC), in which it reported ownership of 9.78 million shares of the company.

Last month, Blue Harbour disclosed reducing its positions in CACI International Inc (NYSE:CACI) and Investors Bancorp Inc. (NASDAQ:ISBC). The fund cut its stake in CACI International Inc (NYSE:CACI) by around 1.18 million shares, currently holding 1.1 million shares, representing 4.9% of the company’s outstanding stock. The fund has been trimming its exposure to CACI International regularly since the third quarter of 2014. Blue Harbour seems to be a big fan of Investors Bancorp Inc. (NASDAQ:ISBC), in which it shed just over 2 million shares, bringing its stake down to 24.60 million shares of the company. As we reported on January 9, Blue Harbour had increased its stake in the company to 26.62 million shares from 22.34 million shares the fund reported in its latest 13F filing.

Charlotte, N.C.-based Babcock & Wilcox Co (NYSE:BWC) is engaged in providing clean energy technology and services, primarily for the nuclear, fossil and renewable power markets. The company also is a premier advanced technology and mission critical defense contractor. Babcock & Wilcox Co (NYSE:BWC) has a market cap of just over $3 billion, and pays an annual dividend of $0.4, on a yield of 1.40.

In November 2014, Babcock & Wilcox Co (NYSE:BWC) announced that its board of directors approved a plan for the tax-free spin-off of the company’s Power Generation business. The spin-off will create two independent, publicly traded companies, Babcock & Wilcox and BWX Technologies. Babcock & Wilcox will comprise the Power Generation business, while BWX Technologies will focus on the Government and Nuclear Operations business, as well as on the Nuclear Operations, Technical Services, Nuclear Energy and mPower businesses. The spin-off is expected to be completed by mid-summer 2015.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!